The Focus for Dentists
As dentists focus on the best oral care health for their patients, safety and comfort are primary concerns. Some researchers have concluded that quality periodontal SRP procedures may even depend upon effective pain control.
Oraqix has an established safety profile, and is administered needle-free, making it a great anesthetic choice for SRP, particularly for patients concerned about receiving an injection.
Click on a Feature
Oraqix is the only FDA-approved, needle-free anesthesia available for scaling and root planing, an important claim for dentists who insist on proven safety and efficacy for their patients.
Oraqix, administered without the needle, provides clinically-proven pain relief for scaling and root planing procedures2 and is preferred by 70% of patients over injectable anesthesia among SRP patients bothered by the prospect of receiving an injection or the after effects of one8. Additionally, because the effect diminishes after 20 minutes on average, returning the patient to normal sensitivity, normal activities can resume soon after the SRP procedure.
Patients who experience reduced pain and increased comfort during procedures may be more likely to return for follow-up care and treatment. Needle-free Oraqix is preferred over injectable anesthesia by 70% of SRP patients bothered by the prospect of receiving an injection or the after effects of one.8
The active pharmaceutical ingredients in Oraqix, lidocaine and prilocaine, have an established safety profile. There is minimal risk for an allergic reaction. Oraqix is not contraindicated on inflamed tissue and can be reapplied to the same pocket up to a maximum of five cartridges.
Consider this:
- Of those patients who were treated for scaling and root planing, 35% reported that the injection was the most bothersome part of treatment8
- 45% of patients surveyed admitted they would be more likely to seek dental treatment if pain relief could be provided without an injection8
- 46% of patients report that post-treatment numbness due to injections is somewhat or quite bothersome, and as much as 64% would accept mild pain just to avoid an injection and post-procedural numbness8
Among SRP patients bothered by the prospect of receiving an injection or the after effects of one:
- 70% of patients prefered Oraqix to injectable anesthesia8
- 80% reported being “very satisfied” or “satisfied” with the efficacy of Oraqix8
- Post-procedural problems were significantly reduced with Oraqix compared to an injection:
- Bothered by numbness: 16% for Oraqix vs. 66% for injection8
- Unpleasant soreness and pain after treatment: 44% for Oraqix vs. 63% for injection8
- Daily activity disruptions: 19% for Oraqix vs. 69% for injection8
2 Van Steenberge D, Bercy P, DeBoiver J, et al. Patient evaluation of a novel noninjectable anesthetic gel: a multicenter crossover study comparing the gel to infiltration anesthesia during scaling and/or root planing. J Periodontal. 2004 75(11):147`-`478.
8 Van Steenberge D, Bercy P, DeBoiver J, et al. Patient evaluation of a novel noninjectable anesthetic gel: a multicenter crossover study comparing the gel to infiltration anesthesia during scaling and/or root planing. J Periodontal. 2004 75(11):147`-`478.